Biomarkers have been suggested in some instances of AF, e.g., in patients with metabolic syndrome having AF, for which Gal-3 and growth/differentiation factor-15 (GDF-15) were suggested to be predictors of AF recurrence [81]. This evidence concerns the gene GDF15 and atrial fibrillation.